Related Experiment Video
Updated: Aug 10, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Role of lipids in osteoporosis
F Parhami1, A Garfinkel, L L Demer
1Division of Cardiology, Department of Medicine, UCLA School of Medicine, Los Angeles, California, USA.
Insights
High cholesterol (hyperlipidemia) may contribute to both cardiovascular disease and osteoporosis through shared mechanisms involving lipid oxidation. Lipid-lowering drugs show potential in reducing both conditions, though the exact pathway is debated.
Area of Science:
- Biomedical Science
- Gerontology
- Metabolic Diseases
Background:
- Cardiovascular disease and osteoporosis are leading causes of morbidity and mortality in aging populations.
- Emerging evidence suggests a shared etiological factor between cardiovascular disease and osteoporosis.
- Hyperlipidemia is implicated as a potential common factor, acting through lipid oxidation pathways.
Purpose of the Study:
- To explore the role of hyperlipidemia in the pathogenesis of both atherosclerotic plaque formation and osteoporosis.
- To investigate the biological mechanisms linking lipid oxidation to cellular differentiation in vascular and bone cells.
- To evaluate the efficacy of lipid-lowering agents in mitigating both cardiovascular calcification and osteoporosis.
Main Methods:
- In vitro studies examining the effects of oxidized lipids on osteoblastic differentiation.
- Ex vivo, in vivo, and clinical studies assessing the impact of lipid-lowering agents.
- Analysis of shared biological pathways involving lipid oxidation in disease development.
Main Results:
- In vitro data indicate that lipid oxidation products promote vascular cell differentiation while inhibiting bone cell differentiation.
- Ex vivo, in vivo, and clinical studies suggest that lipid-lowering therapies can reduce both atherosclerotic calcification and osteoporosis.
- The precise mechanism by which lipid-lowering agents impact osteoporosis (direct vs. indirect) remains under investigation.
Conclusions:
- Hyperlipidemia, through lipid oxidation, may be a unifying etiological factor for cardiovascular disease and osteoporosis.
- Lipid-lowering agents demonstrate therapeutic potential for managing both conditions.
- Further research is needed to elucidate the direct versus indirect effects of lipid reduction on bone health.
Abstract:
Cardiovascular disease and osteoporosis together account for most of the morbidity and mortality in our aging population despite significant improvements in treatment. Recently, converging lines of evidence suggest that these 2 diseases share an etiologic factor--that hyperlipidemia contributes not only to atherosclerotic plaque formation, but also to osteoporosis, following a similar biologic mechanism involving lipid oxidation. In vitro studies indicate that lipid products of oxidation promote osteoblastic differentiation of vascular cells and inhibit such differentiation in bone cells. Ex vivo, in vivo, and clinical studies further suggest that lipid-lowering agents reduce both atherosclerotic calcification and osteoporosis. Whether lipid-lowering agents reduce osteoporosis directly or indirectly through lipid reduction remains controversial.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
